IV Gallium
Showing 1 - 25 of 9,117
Nontuberculous Mycobacterium Infection Trial in United States (Gallium nitrate)
Recruiting
- Nontuberculous Mycobacterium Infection
- Gallium nitrate
-
Birmingham, Alabama
- +8 more
Jan 10, 2023
Breast Cancer Stage IV Trial in Irvine (Gallium-68)
Recruiting
- Breast Cancer Stage IV
-
Irvine, CaliforniaHoag Memorial Hospital Presbyterian
May 26, 2023
Metastatic Prostate Carcinoma, Recurrent Prostate Carcinoma, Stage IV Prostate Cancer AJCC v8 Trial in Houston (Computed
Not yet recruiting
- Metastatic Prostate Carcinoma
- +4 more
- Computed Tomography
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Jul 10, 2022
Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer AJCC v7 Trial in Atlanta (CT
Active, not recruiting
- Castration-Resistant Prostate Carcinoma
- +2 more
- CT (Computed Tomography)
- +2 more
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
Mar 3, 2022
Anatomic Stage IV Breast Cancer AJCC v8, Invasive Breast Lobular Carcinoma, Metastatic Breast Lobular Carcinoma Trial in Atlanta
Recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- +3 more
- Computed Tomography
- +3 more
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
Aug 9, 2022
Biochemically Recurrent Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Metastatic Prostate Carcinoma Trial in Los
Terminated
- Biochemically Recurrent Prostate Carcinoma
- +5 more
- Computed Tomography
- +2 more
-
Los Angeles, CaliforniaUniversity of California at Los Angeles / Jonsson Comprehensive
Oct 19, 2022
Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer American Joint Committee on
Terminated
- Castration-Resistant Prostate Carcinoma
- +4 more
- Computed Tomography
- +2 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Sep 19, 2022
Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer AJCC v8 Trial in San Francisco
Recruiting
- Castration-Resistant Prostate Carcinoma
- +4 more
- 68Ga-PSMA-11
- Positron Emission Tomography (PET)
-
San Francisco, CaliforniaUniversity of California San Francisco
Feb 27, 2022
Advanced Hepatocellular Carcinoma, Stage III Hepatocellular Carcinoma AJCC v8, Stage IIIA Hepatocellular Carcinoma AJCC v8 Trial
Recruiting
- Advanced Hepatocellular Carcinoma
- +7 more
- Computed Tomography
- +2 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Mar 11, 2022
Prostate Adenocarcinoma, Prostate Carcinoma, Stage IIC Prostate Cancer AJCC v8 Trial in San Francisco (Angiogram,
Recruiting
- Prostate Adenocarcinoma
- +9 more
- Angiogram
- +3 more
-
San Francisco, CaliforniaUniversity of California San Francisco
Aug 5, 2022
Biochemically Recurrent Prostate Carcinoma, Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma Trial in
Recruiting
- Biochemically Recurrent Prostate Carcinoma
- +6 more
- Computed Tomography
- +2 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Mar 7, 2022
Prostate Adenocarcinoma, Stage IIB Prostate Cancer AJCC v7, Stage III Prostate Cancer AJCC v7 Trial in Los Angeles (Computed
Completed
- Prostate Adenocarcinoma
- +3 more
- Computed Tomography
- +2 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Jul 1, 2021
Biochemically Recurrent Prostate Carcinoma, Metastatic Prostate Carcinoma, Prostate Adenocarcinoma Trial in Los Angeles
Completed
- Biochemically Recurrent Prostate Carcinoma
- +8 more
- Computed Tomography
- +3 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Sep 29, 2021
Meningioma Trial in Houston (Computed Tomography, Gallium Ga 68-DOTATATE, Positron Emission Tomography)
Recruiting
- Meningioma
- Computed Tomography
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Sep 28, 2022
Prostate Adenocarcinoma, PSA Progression, Recurrent Prostate Carcinoma Trial in Palo Alto (Gallium Ga 68 DOTA-NeoBOMB1, Gallium
Suspended
- Prostate Adenocarcinoma
- +2 more
- Gallium Ga 68 DOTA-NeoBOMB1
- Gallium Ga 68 PSMA-R2
-
Palo Alto, CaliforniaStanford Cancer Institute Palo Alto
May 3, 2022
Biochemically Recurrent Prostate Carcinoma Trial in Duarte (Gallium Ga 68-labeled PSMA-11, Positron Emission Tomography)
Suspended
- Biochemically Recurrent Prostate Carcinoma
- Gallium Ga 68-labeled PSMA-11
- Positron Emission Tomography
-
Duarte, CaliforniaCity of Hope Medical Center
Oct 12, 2022
68Ga-PSMA-11 PET/CT Screening Prior to 177Lu-PSMA-617 Therapy
Enrolling by invitation
- Castration-Resistant Prostate Carcinoma
- +2 more
- Computed Tomography
- +2 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 16, 2023
Adult Medulloblastoma, Childhood Medulloblastoma, Neuroblastoma Trial in Iowa City (drug, procedure, radiation)
Completed
- Adult Medulloblastoma
- +4 more
- gallium Ga 68-edotreotide
- +4 more
-
Iowa City, IowaUniversity of Iowa Hospitals and Clinics
Aug 26, 2021
Cystic Fibrosis Trial in Iowa City, Baltimore, Seattle (100 mg/m2 dose, 200 mg/m2 dose)
Completed
- Cystic Fibrosis
- 100 mg/m2 dose
- 200 mg/m2 dose
-
Iowa City, Iowa
- +2 more
Jan 28, 2019
Recurrent Prostate Carcinoma Trial in Los Angeles, San Francisco (other, procedure, radiation)
Active, not recruiting
- Recurrent Prostate Carcinoma
- Best Practice
- +3 more
-
Los Angeles, California
- +1 more
Feb 2, 2022
Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8 Trial in Seattle
Not yet recruiting
- Castration-Resistant Prostate Carcinoma
- +2 more
- Biopsy
- +9 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Nov 17, 2023
Prostate Adenocarcinoma, Recurrent Prostate Carcinoma Trial in Los Angeles (radiation, other, procedure)
Completed
- Prostate Adenocarcinoma
- Recurrent Prostate Carcinoma
- Gallium Ga 68 Gozetotide
- +2 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Jun 30, 2021
68Ga-PSMA PET in Diagnosing Metastasis in Ovarian Cancer
Recruiting
- Ovarian Carcinoma
- Gallium Ga 68-labeled PSMA-11
- +2 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Oct 12, 2021
Healthy Volunteers, Pancreatic Ductal Adenocarcinoma Trial (RAD301 ([68Ga]-Trivehexin))
Not yet recruiting
- Healthy Volunteers
- Pancreatic Ductal Adenocarcinoma
- RAD301 ([68Ga]-Trivehexin)
- (no location specified)
Mar 22, 2023
Prostatic Tumors, Prostatic Diseases, Prostate Cancer Trial in Portland (68GA PSMA-HBED-CC)
Approved for marketing
- Prostatic Neoplasms
- +4 more
- 68GA PSMA-HBED-CC
-
Portland, OregonOHSU Knight Cancer Institute
Mar 11, 2022